The You always tout the possible benefits to Pluristem's therapies when you post these types of articles. But there is also one very important part you leave out. It bodes well for ALL companies in these spaces.
Could there be a phase 1 trial out there that had tremendous success? Could they now, or soon, get some sort of conditional approval? I'm not saying there is, but it is quite possible don't you think. Companies with deep pocket all realize this and are scrambling to get their products out to the masses as well. All vying for the riches this industry will see. In essence, it kind of sucks for the companies that have spent millions of dollars and years of work, only to have a company step right in and leapfrog a company with early, statistically insignificant results. Personally I find this more of a threat to our company, rather than helping.
Or what if we did get approval in something. How long before a competitor can come around and get something to market relatively quickly. Big company with big marketing could erase a small companies lead rather quickly. Could big pharma be pushing for this type of legislation with this in mind? Again, not really a fan of this from an invesent point of view anyway.
You want to sit there and put down Celularity saying they are years behind right. They are using the same cell source as us right. Do you think they don't know about changes that are coming. Do you not think this is a reason for the hype or the funding they received. The people at their top probably come from engineering backgrounds too right. No vast knowledge of the industry, no relationships formed in every area of Big Pharma, government, FDA. No they're going to sit back and go through the same painful 10 years of trials like we have. But we have patents. They only have 800
But yes, I'm sure the tortoise always wins right. Those that still believe this management is capable, best of luck. Unfortunately we need some serious luck to fall out way with the management team we have in place.
I'm curious to see what happens tomorrow. We did have a nice little gain on high volume. Do we drift right back to much lower volumes. We will see. Certainly hope not. Did out ATM kick in today. I can't stand not being able to find that out.
But there is, imo, an sense of urgency with this management. The AGM is a short few months away. Does anyone think they want to head in there with a price in the $1.30's. How would 5.3 million free shares to the employees sit with the Israeli investors, or any investor in reality. Aside from the usual crew here, it will be hated worse than the 4 million to the twins.
It is a little strange the Chinese show disappearing. Do we see a partnership that is actually signed, or the dreaded binding term sheets. How they're called binding makes no sense to me.
I. wouldn't be surprised to see some insider buys coming through. I truly believe they are feeling some fire under their a$$. Rightfully so.
Whatever it is it better come soon. 2018 has been a bust so far. Soon enough the first quarter of the year will have come and gone. Nothing unusual about that with these guys. Give us some news please...we deserve something don't you think.
AI
